Seeking Alpha
More on AMLN by Jack Haddad
Latest AMLN Transcript
-
Amylin Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript
October 20, 2009
Latest AMLN Articles
-
Wednesday Options Recap
December 23, 2009 • Frederic Ruffy
-
Diabetes Care: Global Investing Opportunities
November 22, 2009 • Mike Havrilla
-
Amylin Takes Lead in Obesity Race
November 3, 2009 • Zacks.com
-
Innovative Drug Companies Headline the Gainers
November 2, 2009 • Ockham Research
-
Amylin Pharma: Calls Ride the Rally
November 2, 2009 • optionMONSTER
-
Don't Expect Amylin to Eat the Obesity Market's Lunch
November 2, 2009 • Ruthanne Williams Roussel
-
Wall Street Breakfast: Must-Know News
October 21, 2009 • SA Editor Eli Hoffmann
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.










Amylin Pharmaceuticals Inc. (AMLN)
Posts on AMLN by Jack Haddad
AMLN continues to have good support at 12.50
Bought AMLN and wrote Nov strike 12.50 calls.
A San Francisco fund has doubled stake in AMLN
Re-entered AMLN and wrote July strike 12.50 calls
Sold entire postion on AMLN and covered July strike 12.50 calls
Bought to cover the last batch of July strike 10 calls on AMLN
Bought AMLN and write July 12.50 calls
Increased position on AMLN and wrote more July strike 12.50 calls
Amylin's Exenatide for type 2 diabetes yielded better results than Merck's Januvia and Takeda
Sold portion of AMLN and bought to cover June strike 12 calls
Added Amln and wrote July strike 10 calls
Activist investor Carl Ichan just won his battle against AMLN.
AMLN's price stability is evident by the Width of its bollinger band
AMLN's MACD is very bullish!
Exinatide will get approved by the FDA for type II diabetes.
AMLN's June strike 10 offer good intrinsic time value for option writers.
Amylin's 25% share pullback as a result of the FDA's rejection of Novo Nordisk's Liraglutide is unjustified.
Posts on AMLN by other instabloggers
-
August 30, 2009
•
Michael Becker
-
July 25, 2009
•
A. Reza Saadat
-
July 21, 2009
•
Dr. Stephen Leeb
-
June 23, 2009
•
Michael Becker
-
June 03, 2009
•
Todd Walker
All instablog posts on AMLN »Three Recent Biotechnology Activist Wins by Carl Icahn
Decoupled moves in Biotech indices highlight opportunities and challenges
Healthcare Where to Buy
Novel Diabetes Therapies Presented at the 2009 ADA Meeting
Icahn & Eastbourne Celebrate Disposal of Amylin's Chairman